These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9152941)

  • 1. Morphometry of abnormal peroxisomes induced by withdrawal of bezafibrate, a hypolipidemic drug in male rat hepatocytes.
    Kondo K; Makita T
    J Vet Med Sci; 1997 Apr; 59(4):297-9. PubMed ID: 9152941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral administration of bezafibrate on peroxisomes and carnitine acetyltransferase in rat hepatocytes.
    Ohue M; Makita T
    J Vet Med Sci; 1994 Jun; 56(3):541-6. PubMed ID: 7948386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural observation of changes in (hepatic) peroxisomes by 3 to 90 days administration of bezafibrate in male rats.
    Kondo K; Makita T
    J Vet Med Sci; 1996 Aug; 58(8):743-8. PubMed ID: 8877972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short- and long-term effects of bezafibrate in the rat.
    Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
    Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of peroxisomal degradation by 3-methyladenine (3MA) in primary cultures of rat hepatocytes.
    Kondo K; Makita T
    Anat Rec; 1997 Apr; 247(4):449-54. PubMed ID: 9096783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.
    Baumgart E; Völkl A; Pill J; Fahimi HD
    FEBS Lett; 1990 May; 264(1):5-9. PubMed ID: 2338145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting.
    Beier K; Völkl A; Hashimoto T; Fahimi HD
    Eur J Cell Biol; 1988 Aug; 46(3):383-93. PubMed ID: 2903052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioautographic study on the intracellular localization of a hypolipidemic agent, bezafibrate, a peroxisome proliferator, in cultured rat hepatocytes.
    Momose Y; Nagata T
    Cell Mol Biol (Noisy-le-grand); 1993 Nov; 39(7):773-81. PubMed ID: 8268762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular organization of hepatocyte peroxisomes.
    Makita T
    Int Rev Cytol; 1995; 160():303-52. PubMed ID: 7558686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species.
    Gray RH; de la Iglesia FA
    Hepatology; 1984; 4(3):520-30. PubMed ID: 6586630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.
    Fahl WE; Lalwani ND; Watanabe T; Goel SK; Reddy JK
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7827-30. PubMed ID: 6096860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study.
    Klinger W; Lupp A; Karge E; Oelschläger H; Rothley D; Danz M; Linss W; Löbel S; Deufel T; Müller M; Klinger M; Kühnel W
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):301-14. PubMed ID: 9784002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalase-negative peroxisomes: transient appearance in rat hepatocytes during liver regeneration after partial hepatectomy.
    Oikawa I; Novikoff PM
    Am J Pathol; 1995 Mar; 146(3):673-87. PubMed ID: 7887449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of automatic image analysis for morphometric studies of peroxisomes stained cytochemically for catalase. II. Light-microscopic application.
    Beier K; Fahimi HD
    Cell Tissue Res; 1987 Jan; 247(1):179-85. PubMed ID: 3829115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical and immunocytochemical study on the peroxisomes of rat liver after administration of a hypolipidemic drug, MLM-160.
    Yokota S
    Eur J Cell Biol; 1990 Oct; 53(1):112-21. PubMed ID: 1981745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348.
    Moody DE; Reddy JK
    J Cell Biol; 1976 Dec; 71(3):768-80. PubMed ID: 993270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
    Duclos S; Bride J; Ramirez LC; Bournot P
    Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat liver peroxisomes after fibrate treatment. A survey using quantitative mass spectrometry.
    Islinger M; Lüers GH; Li KW; Loos M; Völkl A
    J Biol Chem; 2007 Aug; 282(32):23055-69. PubMed ID: 17522052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of phenobarbital on peroxisome biogenesis in mouse hepatocytes.
    Kanamura S; Kanai K; Asaka Y; Watanabe J
    J Ultrastruct Mol Struct Res; 1988 Sep; 100(3):269-77. PubMed ID: 3243975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.